Stocks · Healthcare · Medical - Instruments & Supplies
Pulse Biosciences, Inc. PLSE
$47.90 -3.87% Close, Oct 2, 2026 · NASDAQ · Market cap $3.32B
Strong trend
Next earnings report: Nov 4, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Over the past year the stock returned +164.3%, ahead of the S&P 500 by 149.3 percentage points.
- The stock is in an uptrend: above its 200-day average for 165 trading days, with the 50-day average above the 200-day.
- The company holds net cash of $94.8M (cash above total debt).
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth, 3-year CAGRBottom 7%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 15%
- Gross marginBottom 7%
- Operating marginBottom 5%
- Accruals (lower is better)Top 20%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 37%
- Free-cash-flow yieldTop 41%
- EBITDA / enterprise valueTop 44%
- Sales / enterprise valueBottom 2%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 7%
- 6-month returnTop 7%
- 1-year return vs S&P 500Top 7%
- Distance from 52-week highTop 29%
- Trend checklist (0–4)Top 20%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 46%
- Consecutive EPS beatsBottom 20%
- Share of analysts rating BuyBottom 25%
- Upside to consensus price targetBottom 14%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 34%
- Maximum drawdown, 3 yearsTop 22%
- Beta vs S&P 500 (lower is better)Top 50%
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Gross margin | -21.6% | — | Bottom 7% | |
| Operating margin | -7007.8% | — | Bottom 5% | |
| Net margin | -6755.8% | — | — | |
| Free-cash-flow margin | -5180.4% | — | — | |
| Return on invested capital | -78.1% | — | Bottom 15% | |
| Revenue growth, 3-year CAGR | -20.6% | — | Bottom 7% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -16.4%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 1474.4%
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -1.71%
- Shareholder yield
- -1.71%
- Share count change, 1 year
- +2.9%
- Share count change, 3-year CAGR
- +15.8%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 6, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 6 of 8
- Average EPS surprise, last 4
- +2.0%
- Average 2-day reaction, last 8
- +0.3%
- Positive 20 days after report
- 5 of 8
Analysts
- Consensus price target
- $50.20
- Target vs current price
- +4.8%
- Analysts with a rating
- 5
- Share rating Buy or Strong Buy
- 60%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 6, 2026 | -16.1% | +0.9% | +14.3% | +39.0% | — |
| May 4, 2026 | +15.6% | -3.8% | -8.4% | +18.4% | +64.4% |
| Feb 19, 2026 | +1.9% | -1.5% | -24.5% | -11.6% | +6.4% |
| Nov 5, 2025 | +6.5% | +1.3% | -4.6% | -16.0% | -14.6% |
| Aug 12, 2025 | -7.7% | +1.5% | +5.4% | +0.4% | +7.9% |
| May 8, 2025 | — | +1.0% | -2.3% | -2.2% | -9.7% |
| Mar 27, 2025 | +29.2% | -0.9% | +5.9% | +22.0% | -2.0% |
| Oct 30, 2024 | +33.3% | +4.0% | -3.3% | +19.1% | +13.4% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.36 | -$0.31 | -16.1% | $434,000 |
| May 4, 2026 | -$0.27 | -$0.32 | +15.6% | $400,000 |
| Feb 19, 2026 | -$0.26 | -$0.27 | +1.9% | $264,000 |
| Nov 5, 2025 | -$0.29 | -$0.31 | +6.5% | $86,000 |
| Aug 12, 2025 | -$0.28 | -$0.26 | -7.7% | — |
| May 8, 2025 | -$0.17 | — | — | — |
| Mar 27, 2025 | -$0.17 | -$0.24 | +29.2% | — |
| Oct 30, 2024 | -$0.16 | -$0.24 | +33.3% | — |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 2717.55× | — | — | Bottom 2% |
| Free-cash-flow yield | -1.85% | — | — | Top 41% |
| Earnings yield | -2.44% | — | — | Top 37% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 100
- Days above the 200-day average
- 165
- 50-day average slope (20 days)
- +25.2%
- 200-day average slope (20 days)
- +16.1%
- Distance from 50-day average
- +2.1%
- Distance from 200-day average
- +72.8%
- RSI (14)
- 43.9
- Relative volume
- 0.79×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 65.6%
- Volatility vs own 5-year history
- 24th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.11
- Correlation with S&P 500
- 0.22
- Current drawdown from 1-year high
- -13.2%
- Maximum drawdown, 3 years
- -48.5%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Feb 8, 2021 | Aug 30, 2022 | -97.2% | 393 days | 989 days (Aug 11, 2026) |
| Oct 5, 2020 | Nov 9, 2020 | -26.0% | 25 days | 16 days (Dec 2, 2020) |
| Sep 15, 2026 | Oct 2, 2026 | -13.2% | 13 days | Not yet recovered |
| Jan 8, 2021 | Jan 12, 2021 | -12.3% | 2 days | 3 days (Jan 15, 2021) |
| Sep 3, 2026 | Sep 8, 2026 | -10.8% | 2 days | 5 days (Sep 15, 2026) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $3.32B
- EPS, diluted (TTM)
- -$1.17
- Revenue (TTM)
- $1.2M
- 52-week range
- $12.56 – $58.90
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $1.4M | $700,000 | $0 | $0 | $350,000 |
| Gross profit | -$550,000 | -$11.2M | -$1.2M | $0 | -$1.3M |
| Operating income | -$63.0M | -$58.1M | -$43.6M | -$56.3M | -$76.9M |
| Net income | -$63.7M | -$58.5M | -$42.2M | -$53.6M | -$72.8M |
| EPS (diluted) | -$2.28 | -$1.72 | -$0.88 | -$0.92 | -$1.08 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $86,000 | $264,000 | $401,000 | $434,000 |
| Net income | -$12.7M | -$19.4M | -$16.8M | -$19.2M | -$19.4M | -$17.4M | -$18.6M | -$24.7M |
| EPS (diluted) | -$0.21 | -$0.33 | -$0.25 | -$0.28 | -$0.29 | -$0.26 | -$0.26 | -$0.36 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$54.1M | -$47.0M | -$33.0M | -$36.3M | -$54.1M |
| Capital expenditure | -$437,000 | -$401,000 | -$121,000 | -$125,000 | -$315,000 |
| Free cash flow | -$54.5M | -$47.4M | -$33.2M | -$36.5M | -$54.4M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $56.7M | $14.9M | $16.4M | $59.6M | $17.2M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $101.6M
- Total assets
- $115.6M
- Total liabilities
- $16.1M
- Total debt
- $6.8M
- Net debt
- -$94.8M
- Shareholders’ equity
- $99.5M
As of Jun 30, 2026 (filed Aug 6, 2026).
Short interest
- Shares sold short
- 3,139,674
- Days to cover
- 3.89
- Change vs previous report
- +0.6%
FINRA short interest, settlement date Sep 15, 2026.